0000950170-24-077930.txt : 20240626
0000950170-24-077930.hdr.sgml : 20240626
20240626165445
ACCESSION NUMBER: 0000950170-24-077930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240624
FILED AS OF DATE: 20240626
DATE AS OF CHANGE: 20240626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shair Matthew
CENTRAL INDEX KEY: 0001862123
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40671
FILM NUMBER: 241074316
MAIL ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvalent, Inc.
CENTRAL INDEX KEY: 0001861560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 508-446-2272
MAIL ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
ownership.xml
4
X0508
4
2024-06-24
0001861560
Nuvalent, Inc.
NUVL
0001862123
Shair Matthew
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
true
false
false
false
true
Class A Common Stock
2024-06-24
4
S
false
634
79.47
D
233888
I
See Footnote
Class A Common Stock
2024-06-24
4
S
false
1176
80.50
D
232712
I
See Footnote
Class A Common Stock
2024-06-24
4
S
false
190
80.98
D
232522
I
See Footnote
Class A Common Stock
1427197
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.88 to $79.87, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5) of this Form 4.
These shares are held by Matthew D. Shair 2021 Irrevocable Family Trust. The reporting person has voting and dispositive power over the shares beneficially owned by Matthew D. Shair 2021 Irrevocable Family Trust.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $80.87, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.89 to $81.15, inclusive.
/s/ Nathan McConarty, attorney-in-fact
2024-06-26